| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hemostemix Inc (V: HEM)
HEM Technical Analysis
4
| As on 20th Dec 2024 HEM STOCK Price closed @ 0.08 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.09 & Strong Sell for SHORT-TERM with Stoploss of 0.12 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HEMSTOCK Price
| Open | 0.08 | Change | Price | % |
| High | 0.08 | 1 Day | 0.00 | 0.00 |
| Low | 0.08 | 1 Week | 0.02 | 33.33 |
| Close | 0.08 | 1 Month | -0.01 | -11.11 |
| Volume | 20337 | 1 Year | -0.05 | -38.46 |
| 52 Week High 0.17 | 52 Week Low 0.04 | ||||
V Canada Most Active Stocks
| NU | 14.06 | -7.44% |
| QNC | 0.44 | 29.41% |
| GXU | 0.06 | 20.00% |
| FUU | 0.24 | 0.00% |
| DM | 0.00 | -100.00% |
| LITH | 0.81 | 10.96% |
| STUD | 0.03 | 0.00% |
| VXTR | 0.05 | 0.00% |
| WCU | 0.06 | 0.00% |
| SYH | 0.37 | 15.62% |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
| HEM Daily Charts |
HEM Intraday Charts |
Whats New @ Bazaartrend |
HEM Free Analysis |
|
|
HEM Important Levels Intraday
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
HEM Forecast December 2024
| 4th UP Forecast | 0.23 |
| 3rd UP Forecast | 0.18 |
| 2nd UP Forecast | 0.15 |
| 1st UP Forecast | 0.12 |
| 1st DOWN Forecast | 0.04 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | -0.02 |
| 4th DOWN Forecast | -0.07 |
HEM Weekly Forecast
| 4th UP Forecast | 0.08 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.08 |
| 1st UP Forecast | 0.08 |
| 1st DOWN Forecast | 0.08 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | 0.08 |
| 4th DOWN Forecast | 0.08 |
HEM Forecast2024
| 4th UP Forecast | 0.35 |
| 3rd UP Forecast | 0.26 |
| 2nd UP Forecast | 0.21 |
| 1st UP Forecast | 0.16 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.1 |
| 4th DOWN Forecast | -0.19 |
Hemostemix Inc ( V Canada Symbol : HEM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HEM Business Profile
Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. It develops cell therapy products from the patient's own blood, a relatively non-invasive source of therapeutic cells. The company's lead product is ACP-01, an autologous cell therapy for the treatment of critical limb ischemia, which is in Phase II clinical trial in Canada and the United States. It is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. The company is headquartered in Calgary, Canada. Address: 707-7th Avenue SW, Calgary, AB, Canada, T2P 3H6
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service